2025 annual financial data
Lakefront Biotherapeutics 2025 Operating margin
Lakefront Biotherapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was 45.08%.
Operating income was 501,391,000 EUR and net income was 320,884,000 EUR.
Operating cash flow was -257,456,000 EUR.
Get free Lakefront Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,112,248,000 EUR
- Operating income
- 501,391,000 EUR
- Net income
- 320,884,000 EUR
- Operating cash flow
- -257,456,000 EUR